Scott G. Stephen - 12 Mar 2021 Form 4/A - Amendment Insider Report for cbdMD, Inc. (YCBD)

Role
Director
Signature
/s/ Scott Stephen
Issuer symbol
YCBD
Transactions as of
12 Mar 2021
Net transactions value
$0
Form type
4/A - Amendment
Filing time
05 Oct 2021, 13:43:37 UTC
Date Of Original Report
16 Mar 2021
Next filing
19 Apr 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction YCBD Common stock Award $0 +5,000 +12% $0.000000 46,052 12 Mar 2021 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents restricted stock units. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. The grant was exempt from Section 16(b) under the Securities Exchange Act of 1934 by virtue of Rule 16b-3 promulgated thereunder as it was approved in advance by the Issuer's Compensation, Corporate Governance and Nominating Committee, which is comprised of three non-employee directors. The restricted stock units vest quarterly in equal increments over a one year period from the grant date with the last vesting being on March 12, 2022, subject to continued service as a director of the Issuer on each applicable vesting date. Shares of common stock will be delivered to the Reporting Person upon the vesting of the restricted stock units. The restricted stock units were issued under the 2021 Equity Compensation Plan as compensation to the Reporting Person for his services on the Issuer's Board of Directors for the Board term beginning March 12, 2021.

Remarks:

The original Form 4 filed on March 16, 2021 is amended by this Form 4 to disclose the restricted stock units as a non-derivative security. No other changes have been made to the original Form 4.